NCT03976999 Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers
| NCT ID | NCT03976999 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle |
| Condition | Carcinoma, Ovarian Epithelial |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2017-07-05 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2017-07-05 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical datas to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to epithetial ovarian cancer, Fallopian tube cancer and Primitive peritoneal cancer.
Eligibility Criteria
Inclusion Criteria: * 18 or older * Patient at the diagnosis of an epithelial ovarian cancer, or a fallopian tube caner or a primitive peritoneal cancer * Patient eligible for, at least, one surgery and a chemotherapy * Patient having given his informed, written and express consent Exclusion Criteria: * Patient not affiliated to a social protection scheme * Pregnant and / or nursing women * Subject under tutelage, curatorship or safeguard of justice * Patient whose regular follow-up is impossible for psychological, familial, social or geographical reasons
Contact & Investigator
COLOMBO Pierre-Emmanuel, M.D
PRINCIPAL INVESTIGATOR
ICM - Institut régional du Cancer Montpellier
Frequently Asked Questions
Who can join the NCT03976999 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Carcinoma, Ovarian Epithelial. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03976999 currently recruiting?
Yes, NCT03976999 is actively recruiting participants. Contact the research team at DRCI-icm105@icm.unicancer.fr for enrollment information.
Where is the NCT03976999 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT03976999 clinical trial?
NCT03976999 is sponsored by Institut du Cancer de Montpellier - Val d'Aurelle. The principal investigator is COLOMBO Pierre-Emmanuel, M.D at ICM - Institut régional du Cancer Montpellier. The trial plans to enroll 300 participants.